Ophthalmic devices are those devices which are used for vision correction or in ophthalmic diagnostic procedures. A corneal implant is a naturally based or artificially engineered cornea that is implanted onto an eye of a patient to replace his or her damaged or diseased cornea. GlobalData uses proprietary data and analytics to provide a comprehensive report on the corneal implants devices market, including market shares of different players within India. Buy the latest report here.

Smarter leaders trust GlobalData


Premium Insights India Corneal Implants Market Share

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

In 2022, GlobalData’s Market Model methodology determined that the leading player in the corneal implants market in India was Sightlife followed by AJL Ophthalmic and Massachusetts Eye and Ear Infirmary.

Corneal Grafts, Keratoprostheses and Intrastromal Corneal Rings Segment (ICRS) are tracked under this market.

Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the corneal implants devices market within India was expected to be over $30m in 2022.

For the latest complete market share analysis of corneal implants device market in India, buy the report here.

Premium Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.